Latest News

Thursday, October 30, 2014 | Miscellaneous

Omidria Granted Pass-Through Reimbursement Status from CMS

Omeros announced that it has received transitional pass-through status for its lead product Omidria (phenylephrine and ketorolac injection) 1%/0.3% from the Center for Medicare & Medicaid Services…

Read the full story

Thursday, October 30, 2014 | Product Releases

MacPractice 20/20 5 Announced with MacPractice EMR and New EHR/iEHR

MacPractice announced the launch of MacPractice 20/20 5 EHR system, according to a company news release. In addition to MacPractice EMR, Yosemite-compatible MacPractice 20/20 5 offers a new MacPr…

Read the full story

Thursday, October 30, 2014 | Retina

RetroSense Therapeutics Granted Orphan Drug Designation for Lead Product RST-001 for Retinitis Pigmentosa

RetroSense Therapeutics LLC announced that the FDA has granted orphan drug designation for the company’s lead product RST-001 for the treatment of retinitis pigmentosa (RP), according to a compa…

Read the full story

Thursday, October 30, 2014 | Medical Studies

Virtual Patients Come Alive in New Simulation Lab at University of Houston

This fall, University of Houston (UH) optometry students began hands-on training in a first-of-its-kind simulation lab that offers them 24/7 access to virtual patients. The Optometric Clinical Skills …

Read the full story

Thursday, October 30, 2014 | Medical Studies

Experimental Plug Aids Recovery From Cataract Surgery

A tapered-release dexamethasone punctum plug appears to be a reasonable alternative to medicated eye drops for patients who have undergone cataract surgery, according to early research. "In clini…

Read the full story

Wednesday, October 29, 2014 | Product Releases

Johnson & Johnson Introduces Initial US Launch of 1-Day Acuvue Define Brand Contact Lenses

Johnson & Johnson Vision Care announced the initial launch of 1-Day Acuvue Define Brand Contact Lenses with Lacreon Technology, a new category of eye enhancement contact lenses that accentuate nat…

Read the full story

Wednesday, October 29, 2014 | Medical Studies

AMD May Progress at a Similar Rate in the Other Eye

The severity of age-related macular degeneration in one eye seems to pace the rate of degeneration in the other eye, new research has found. "In a cohort that was observed for 20 years, we showed…

Read the full story

Wednesday, October 29, 2014 | Medical Studies

iPhones for Eye Health: Capturing Ocular Images in Difficult-to-Photograph Patients

Smartphone technology is a widely available resource which may also be a portable and effective tool for imaging the inside of the eye, according to results of a study released today at AAO. Researche…

Read the full story

Tuesday, October 28, 2014 | Medical Studies

Retina Health Center Develops Imaging Device for Monitoring Patient Eye Drop Technique and Compliance

Understanding patient compliance with an eye drop regimen can greatly affect an ophthalmologist’s choice in treatments, though physicians rarely know how compliant a patient is without proper mo…

Read the full story

Tuesday, October 28, 2014 | Clinical Trials

TxCell Achieves Positive Results for Col-Treg in a Model of Autoimmune Uveitis

TxCell SA announced that TxCell researchers have achieved positive results for Col-Treg, its second product candidate from its ASTrIA platform, in a model of autoimmune uveitis, a leading cause of bli…

Read the full story

Tuesday, October 28, 2014 | Medical Studies

Pitt Researchers Receive $1.25 Million From Defense Department to Make Whole-Eye Transplantation a Reality

University of Pittsburgh School of Medicine researchers have been awarded $1.25 million from the U.S. Department of Defense (DOD) to fund two projects that aim to establish the groundwork for the nati…

Read the full story

Tuesday, October 28, 2014 | Medical Studies

AMD May Progress at a Similar Rate in the Other Eye

The severity of age-related macular degeneration (AMD) in one eye seems to pace the rate of degeneration in the other eye, new research has found. "In a cohort that was observed for 20 years, we …

Read the full story

Monday, October 27, 2014 | Acquisitions/Mergers, Valeant Ophthalmics

Valeant Ready to Raise Allergan Bid to at Least $200/share

Valeant Pharmaceuticals International Inc. on Monday said in a letter to Allergan Inc's board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of d…

Read the full story

Monday, October 27, 2014 | Medical Studies

Squints Can be Treated at Any Age - Examination of Children Important in Their First Year of Life

Around 4% of all newborn children have a squint. In about 50 per cent of cases, this can be corrected with appropriate glasses, however the other half require treatment for their squint and in some ca…

Read the full story

Monday, October 27, 2014 | Miscellaneous

The Royal College of Ophthalmologists Calls for the All Party Parliamentary Group for Eye Health

The All Party Parliamentary Group (APPG) for Eye Health and Visual Impairment met with representatives from The Royal College of Ophthalmologists (RCOphth) and the College of Optometrists to discuss t…

Read the full story
Load More

Advertisement

 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $24.79  0.00% 
 Akorn, Inc. $43.64  0.00% 
 Alimera Sciences, Inc. $6.02  0.00% 
 Allergan, Inc. $189.44  0.00% 
 Bayer $139.12  0.00% 
 Can-Fite Biopharma $2.83  0.00% 
 Carl Zeiss Meditec $21.79  1.66% 
 Cooper Companies, Inc. $163.66  0.00% 
 Escalon Medical Corp. $1.33  0.00% 
 Essilor International $108.00  0.00% 
 Imprimis Pharmaceuticals, Inc. $8.71  0.00% 
 InSite Vision, Inc. $0.28  0.00% 
 IRIDEX Corporation $6.75  0.00% 
 Johnson & Johnson $107.04  0.00% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $50.64  0.00% 
 Merck & Company, Inc. $57.31  0.00% 
 NicOx $2.14  -0.14% 
 NovaBay Pharmaceuticals, Inc. $0.80  0.00% 
 Novartis AG Common Stock $91.95  0.00% 
 Ophthotech Corporation $41.81  0.00% 
 Quantel $3.23  0.31% 
 Roche $37.18  0.00% 
 STAAR Surgical Company $11.04  0.00% 
 TearLab Corporation $2.90  0.00% 
 TLC VISION CORP $0.00  0.00% 
 Topcon Corporation $22.46  0.00% 
 Valeant Pharmaceuticals $131.79  1.56%